Sandra G. Stoneman - 28 May 2021 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
General Counsel and CLO
Signature
/s/ Purnanand D. Sarma, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
28 May 2021
Net transactions value
$0
Form type
4
Filing time
01 Jun 2021, 19:19:35 UTC
Next filing
21 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock Option (Right to Buy) Award $0 +16,609 $0.000000 16,609 28 May 2021 Common Stock 16,609 $20.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on May 28, 2022, and one-thirty-sixth (1/36th) of the remaining shares subject to the option shall vest every month thereafter.